HHS plan to speed drug research won’t remove ‘self-inflicted’ delays

Summary

The article discusses an HHS initiative called Operation Trialblazer aimed at accelerating drug research in the U.S. as clinical trials continue to lose ground to China, though questions remain about whether the plan adequately addresses inherent delays in the research process.